George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.50
Bid: 103.00
Ask: 108.00
Change: -0.50 (-0.47%)
Spread: 5.00 (4.854%)
Open: 105.50
High: 105.00
Low: 105.00
Prev. Close: 105.50
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

1 Dec 2011 07:00

RNS Number : 0632T
Intercede Group PLC
01 December 2011
 



 

 

1 DECEMBER 2011

 

INTERCEDE GROUP plc

('Intercede', 'the Company' or 'the Group')

 

Interim Results for the Six Months Ended 30 September 2011

 

 

Intercede (AIM: IGP.L) is a leading producer of Identity and Credential Management software, called MyID, which manages the secure registration, issuance and life cycle of digital identities for a wide range of uses.

 

SUMMARY

 

- Sales of £3,528,000 (2010: £3,506,000);

 

- Underlying revenues have increased by 25%, excluding the Boeing contract which was worth more than £1m in H1 2010;

 

- Operating profit of £617,000 (2010: £1,204,000);

 

- 23% increase in cost base reflects planned investment in business expansion, principally sales and product development;

 

- Basic and fully diluted earnings per share of 1.4p (2010: 2.5p);

 

- Cash balances of £6,563,000 at 30 September 2011 (30 September 2010: £4,470,000);

 

- Significant endorsement of Intercede's proprietary MyID Identity and Credential Management System as an industry standard;

 

- Increasing collaboration with Microsoft in the US;

 

- New partnership agreement with Hewlett Packard in support of the HP Assured Identity Product Suite;

 

- Winning new contracts to supply MyID to government ministries, banks and business corporations around the world.

 

 

Richard Parris, Chairman & Chief Executive of Intercede, said today:

 

"There have been a number of notable commercial successes during the period demonstrating the fundamental strength and growth trajectory of the business. Our financial position remains strong, with no debt and cash balances up almost 50% year on year.

 

"We have also invested heavily in sales and product development in order to pursue a greater number of opportunities. Our own sales efforts are complemented by partnerships with some of the largest IT industry players in the world, enabling us to punch above our weight.

 

"We believe that this period's results provide further evidence of our ability to execute to plan. The Board remains confident in its long term growth strategy to create significant shareholder value through continuing global market penetration and technology excellence in the burgeoning cyber security industry."

 

ENQUIRIES

 

Intercede Group plc

Tel. +44 (0)1455 558 111

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

 

 

FinnCap

Tel. +44 (0)20 7600 1658

Charles Cunningham, Corporate Finance

Rose Herbert, Corporate Finance

Joanna Weaving, Corporate Broking

 

 

Pelham Bell Pottinger

Tel. +44 (0)20 7861 3112

Archie Berens

Clare Gilbey

 

About Intercede

Intercede is the producer of the MyID Identity and Credential Management System (IDCMS).

Intercede MyID technology is being used around the world by large corporations, governments and banks to manage millions of identities for employees, citizens and customers. Notable deployments in the US include 14 federal agencies, two million smart cards in support of the US Transportation Worker Identity Credential program (TWIC), four US financial institutions and 320,000 smart corporate identity badges for Boeing, Booz Allen Hamilton and Lockheed Martin. In Europe, Australasia and the Middle East, Intercede MyID is being deployed in support of government identity, financial services, health and corporate employee ID security projects.

Intercede MyID is the only IDCMS software product that enables organizations to easily and securely manage the identities of people and their associated identity credentials within a single, integrated, workflow driven platform. This includes enabling and managing secure registration, biometric capture, application vetting and approval through to smart card personalization, issuance and management.

Intercede MyID was the first electronic personalization product to achieve compliance with the US FIPS-201 Personal Identity Verification (PIV) standard and is widely deployed by federal agencies, government contractors and other commercial entities. In particular, it supports the latest standards applicable for all PIV, PIV-Interoperable and PIV-Compatible deployments.

It can issue and manage a wide variety of IDs and credentials, providing customers with a platform that can meet their needs now and in the future. It is a fully supported commercial off-the-shelf product that can be quickly deployed for thousands or millions of users.

For more information visit www.intercede.com

INTERCEDE GROUP plc

('Intercede', 'the Company' or 'the Group')

 

Interim Results for the Six Months Ended 30 September 2011

 

Chairman's Statement

 

In the period ended 30 September 2011, revenues totalled £3.53m compared to £3.51m in the previous year. However, it should be noted that the previous period included a single contract of more than £1m from Boeing, whereas there was no equivalent contract in the first half of the current financial year. If revenues from the Boeing contract are excluded from both periods, there has been a 25% underlying increase in revenues year on year, demonstrating the fundamental strength of the business and its ongoing growth trajectory.

 

Profit for the period is £0.7m compared to £1.2m in the prior year. This reduction reflects planned investment to accelerate the growth of the business. As previously reported, the goals for the current financial period are to increase sales and marketing efforts in promoting MyID and to extend product development in areas such as mobile devices and further collaboration with Microsoft. The average number of employees and contractors increased from 56 to 67 year on year in support of these goals. Staff costs continue to represent the main area of expense totalling 79% of the total operating costs during the period (2010: 81%).

 

The Company continues to be cash generative. Through careful cash management, the cash balance at the end of September was £6.56m compared to £6.05m at the end of March 2011 and £4.47m at the end of September 2010; a year on year increase of over £2m.

 

There have been a number of commercial successes and industry milestones achieved in the period, including the following:

 

·;

Continuing implementation of large scale corporate identity card projects in ANZ Bank, Booz Allen Hamilton, BASF, Boeing, HealthSmart Australia, Lockheed Martin and Swedbank;

 

·;

Delivery of services to support major MyID system upgrades in US Federal Aviation Authority, Kuwait Public Authority for Civil Information, Road Safety Authority Ireland;

 

·;

Deployment of MyID to issue ID cards to members of the newly elected Portuguese Parliament;

 

·;

The securing of a large scale border security project with an initial value in excess of £0.6m;

 

·;

Increasing collaboration with Microsoft in the US and the first confirmed sale to a corporate customer of the Intercede MyID connector for Forefront Identity Manager;

 

·;

Teaming with Atos, Verisec, the Post Office and Thales to win the London Identity Provider framework contract;

 

·;

Collaboration with major systems integrators on multiple tender responses for large scale US Federal identity programs requiring PIV and PIV-I solutions;

 

·;

The development of a new technology to enable the over-the-air (OTA) provisioning of digital certificates to mobile devices;

 

·;

The development of a new technology to support the use of mobile devices containing Near Field Communications (NFC) for personal identity verification purposed;

 

·;

The continuous improvement of the core MyID platform including the release of MyID v8 Enterprise SP2 and MyID v9 PIV Service Pack 1; and

 

·;

The award of ISO9001 and TickIT certification to Intercede, as announced on 14 September 2011.

 

 

 

We were also delighted to announce on 14 November 2011 that an agreement has been entered into with Hewlett Packard ("HP"), whereby the HP Global Identity Practice can now deliver MyID as a component of their Assured Identity Plus solutions. Under the agreement, Intercede and HP will target large scale Federal, state and local government agencies and major enterprise customers.

 

The progress outlined above demonstrates the effectiveness of Intercede's sales strategy. By focusing on major industry players as channel partners, Intercede has continued to punch above its weight in a way that would not be possible with a more conventional direct sales structure. Intercede has significantly multiplied its future revenue potential by accessing the sales teams and sales infrastructure of partners such as Microsoft, HP, multiple US systems integrators, Atos, Gemalto, Oberthur, Swisscom, Symantec and Thales. Each channel will need continuing sales and technical account management to maximise the return on investment.

 

This channel strategy has enabled Intercede to compete in new territories during the period in a way we could not have reached with a direct team.

 

Our commercial model continues to be market tested through competition with industry rivals. To date, the evidence is that we win most opportunities on technical merit, even though we are not usually the lowest cost bidder. Customer feedback is that we consistently represent the 'best value' supplier.

 

I am pleased that we continue to grow underlying new software license revenues at a healthy rate. Annuity revenue from existing customers as a percentage of total sales is also increasing towards the long term goal of being able to support the cost of our operations from recurring income. It is a characteristic of the business that every £1 of new customer license revenue in a period typically generates a further £2 from associated maintenance plus additional fees from professional services and development activities over future periods. This means that Intercede has already locked in significant future value beyond that disclosed in the current period's accounts.

 

Our research activities in the mobile communications sector have spawned product line extensions that open new markets in the telecommunications market with potential uses for identity verification in the citizen and consumer spaces. This also serves to protect our existing market position should mobile devices overtake smart cards as the principal means of asserting strong identity.

 

We believe that this period's results are evidence of our ability to execute to plan. The Board remains confident in its long term growth strategy to create significant shareholder value through continuing global market penetration and technology excellence in the burgeoning cyber security industry.

 

 

Richard Parris

Chairman & Chief Executive

1 December 2011

 

 

 

 

Consolidated Statement of Comprehensive Income

For the period ended 30 September 2011

 

6 months ended

6 months ended

Year ended

30 September

30 September

31 March

2011

2010

2011

£'000

£'000

£'000

Continuing operations

Revenue

3,528

3,506

6,872

Cost of sales

(94)

(8)

(22)

__________

__________

__________

Gross profit

3,434

3,498

6,850

Administrative expenses

(2,817)

(2,294)

(4,898)

__________

__________

__________

Operating profit

617

1,204

1,952

Finance income

36

21

53

__________

__________

__________

Profit before tax

653

1,225

2,005

Taxation

47

-

(7)

__________

__________

__________

Profit for the period

700

1,225

1,998

__________

__________

__________

Total comprehensive income attributable to owners of the company

700

1,225

1,998

__________

__________

__________

Earnings per share (pence)

- basic

1.4p

2.5p

4.1p

- diluted

1.4p

2.5p

4.1p

__________

__________

__________

 

 

 

Consolidated Balance Sheet

As at 30 September 2011

 

 

As at

As at

As at

30 September

30 September

31 March

2011

2010

2011

£'000

£'000

£'000

Non-current assets

Property, plant and equipment

162

152

167

Deferred tax

280

280

280

__________

__________

__________

442

432

447

__________

__________

__________

Current assets

Trade and other receivables

1,460

1,867

841

Cash and cash equivalents

6,563

4,470

6,046

__________

__________

__________

8,023

6,337

6,887

__________

__________

__________

Total assets

8,465

6,769

7,334

__________

__________

__________

Equity

Share capital

484

4,413

484

Share premium account

86

4,718

86

Other reserves

1,508

1,508

1,508

Retained earnings

3,833

(6,272)

3,113

__________

__________

__________

Total equity

5,911

4,367

5,191

__________

__________

__________

Current liabilities

Trade and other payables

772

773

790

Deferred revenue

1,782

1,629

1,353

__________

__________

__________

2,554

2,402

2,143

__________

__________

__________

Total equity and liabilities

8,465

6,769

7,334

__________

__________

__________

 

 

 

Consolidated Statement of Changes in Equity

As at 30 September 2011

 

 

Share

Share

Other

Retained

Total

capital

premium

reserves

earnings

£'000

£'000

£'000

£'000

£'000

At 31 March 2011

484

86

1,508

3,113

5,191

Total comprehensive income

-

-

-

700

700

Credit in respect of share based payments

-

-

-

20

20

________

________

________

________

_______

At 30 September 2011

484

86

1,508

3,833

5,911

________

________

________

________

________

 

 

At 31 March 2010

4,413

4,718

1,508

(7,497)

3,142

Total comprehensive income

-

-

-

1,225

1,225

________

________

________

________

_______

At 30 September 2010

4,413

4,718

1,508

(6,272)

4,367

________

________

________

________

________

 

 

At 31 March 2010

4,413

4,718

1,508

(7,497)

3,142

Capital reduction

(3,931)

(4,718)

-

8,649

-

Issue of shares, net of costs

2

86

-

-

88

Purchase of treasury shares

-

-

-

(37)

(37)

Total comprehensive income

-

-

-

1,998

1,998

________

________

________

________

_______

At 31 March 2011

484

86

1,508

3,113

5,191

________

________

________

________

________

 

 

Consolidated Cash Flow Statement

For the period ended 30 September 2011

6 months ended

6 months ended

Year ended

30 September

30 September

31 March

2011

2010

2011

£'000

£'000

£'000

Cash flows from operating activities

Operating profit

617

1,204

1,952

Depreciation

33

21

51

Credit in respect of share based payments

20

-

-

(Increase)/decrease in trade and other receivables

(615)

(904)

116

Increase/(decrease) in trade and other payables

410

309

50

__________

__________

__________

Cash generated from operations before exceptional item

465

630

2,169

Exceptional item

-

(747)

(747)

Taxation

47

-

(7)

__________

__________

__________

Net cash generated from/(used by) operating activities

512

(117)

1,415

__________

__________

__________

Investing activities

Interest received

33

12

50

Purchases of property, plant and equipment

(28)

(89)

(134)

__________

__________

__________

Net cash generated from/(used by) investing activities

5

(77)

(84)

__________

__________

__________

Financing activities

Proceeds on issue of shares

-

-

88

Purchase of treasury shares

-

-

(37)

__________

__________

__________

Net cash from financing activities

-

-

51

__________

__________

__________

Net increase/(decrease) in cash and cash equivalents

517

(194)

1,382

Cash and cash equivalents at the beginning of the period

6,046

4,664

4,664

__________

__________

__________

Cash and cash equivalents at the end of the period

6,563

4,470

6,046

__________

__________

__________

 

 

Notes to the Accounts

For the period ended 30 September 2011

 

1 Preparation of the interim financial statements

These interim financial statements have been prepared under IFRS as adopted by the European Union and on the basis of the accounting policies set out in the Group's Annual Report for the year ended 31 March 2011.

 

The Group is not required to apply IAS 34 Interim Financial Reporting at this time.

 

These interim financial statements have not been audited and do not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 March 2011 have been delivered to the Registrar of Companies. The Auditors' Report on those accounts was unqualified and did not contain any statement under Section 498 (2) or (3) of the Companies Act 2006.

 

The Interim Report will be mailed to shareholders prior to the end of December 2011 and copies will be available on the website (www.intercede.com) and at the registered office: Intercede Group plc, Lutterworth Hall, St Mary's Road, Lutterworth, Leicestershire, LE17 4PS.

 

2 Revenue

All of the Group's revenue, operating profits and net assets originate from operations in the UK. The Directors consider that the activities of the Group constitute a single business segment.

 

The split of revenue by geographical destination of the end customer can be analysed as follows:

 

 

6 months ended

6 months ended

Year ended

30 September

30 September

31 March

2011

2010

2011

£'000

£'000

£'000

UK

399

838

1,369

Rest of Europe

377

351

928

USA

1,801

2,032

3,965

Rest of World

951

285

610

__________

__________

__________

3,528

3,506

6,872

__________

__________

__________

 

 

 

3 Taxation

Taxation represents the net effect of amounts received from HMRC in respect of research and development claims and US corporation tax payable. There is no charge for UK corporation tax due to the availability of losses brought forward from prior years.

 

 

4 Earnings per share

The calculations of earnings per ordinary share are based on the profit for the period and the weighted average number of ordinary shares in issue during each period.

 

 

6 months ended

6 months ended

Year ended

30 September

30 September

31 March

2011

2010

2011

£'000

£'000

£'000

Profit for the period

700

1,225

1,998

__________

__________

__________

Number

Number

Number

Weighted average number of shares

- basic

48,365,005

48,178,005

48,239,997

- diluted

49,120,843

48,735,005

48,735,005

__________

__________

__________

Pence

Pence

Pence

Earnings per share

- basic

1.4p

2.5p

4.1p

- diluted

1.4p

2.5p

4.1p

__________

__________

__________

 

The increase in the weighted average number of shares used for the calculation of diluted earnings per share reflects the grant of share options to directors and senior managers during July and August 2011. The total charge for the period relating to employee share-based payments was £20,000 (2010: £nil).

 

5 Dividend

The Directors do not recommend the payment of a dividend.

 

6 Changes in equity

On 24 September 2010, shareholder approval was obtained at a General Meeting of the company to cancel the share premium account and to cancel and extinguish the deferred shares. This Capital Reduction was registered by the Registrar of Companies on 30 October 2010.

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR LLFELLELIVIL
Date   Source Headline
26th Apr 202410:02 amRNSShare Incentive Scheme
23rd Apr 20247:00 amRNSCapital Markets Day
8th Apr 20247:00 amRNSTrading Update
2nd Apr 20247:00 amRNSContract and Subscription Renewals
25th Mar 20243:38 pmRNSHolding(s) in Company
25th Mar 20243:35 pmRNSHolding(s) in Company
22nd Mar 20247:00 amRNSNew Orders and Trading Update
21st Mar 20247:00 amRNSNew Product Announcement: Launch of MyID MFA v5
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
29th Jan 20247:00 amRNSNew Orders
18th Jan 20249:55 amRNSDirector/PDMR Shareholding
3rd Jan 20247:00 amRNSMajor New Contract Win
7th Dec 20237:00 amRNSUpdate on Major New Contract Win
5th Dec 202312:30 pmRNSMajor New Contract with Large US Federal Agency
22nd Nov 20237:00 amRNSDirector/PDMR Shareholding
21st Nov 20237:01 amRNSNew Contract and Renewal Orders
21st Nov 20237:00 amRNSHalf-year Report
7th Nov 20237:00 amRNSContract and Renewals Orders
25th Oct 20234:44 pmRNSDirector/PDMR Shareholding
24th Oct 20237:00 amRNSNotice of Interim Results & Investor Presentation
20th Oct 20237:03 amRNSAppointment of Non-Executive Director
11th Oct 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20237:00 amRNSTrading Update
21st Sep 20231:31 pmRNSResult of AGM
4th Sep 20237:00 amRNSContract and Renewals Orders
30th Aug 20237:10 amRNSNotice of AGM and Publication of Annual Report
20th Jun 20237:01 amRNSBoard Changes
20th Jun 20237:00 amRNSFinal Results
12th Jun 20237:00 amRNSNotice of Results & Investor Presentation
27th Apr 20237:00 amRNSShare Incentive Plan
17th Apr 20237:00 amRNSTrading Update
3rd Apr 20237:00 amRNSContract wins/renewals
3rd Feb 202310:46 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSChange of Auditors
23rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20234:35 pmRNSPrice Monitoring Extension
23rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
23rd Jan 20232:00 pmRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSTrading Update
11th Jan 20232:30 pmRNSDirector/PDMR Shareholding
2nd Dec 20228:45 amRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSHalf-year Report
11th Nov 20227:00 amRNSNotice of Interim Results & Investor Presentation
13th Oct 202210:30 amRNSDirector/PDMR Shareholding
11th Oct 20221:00 pmRNSDirector/PDMR Shareholding
10th Oct 20228:00 amRNSLong Term Incentive Plan
10th Oct 20227:01 amRNSAcquisition of Authlogics Ltd
10th Oct 20227:00 amRNSTrading Update
28th Sep 202212:22 pmRNSResult of AGM
15th Sep 20227:00 amRNSDirector/PDMR Shareholding and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.